Oncology (United States)

Aims & Scope

The journal ONCOLOGY (ISSN: 0890-9091) is published monthly and is geared toward the practicing oncologist.

It focuses on practical issues related to the care of patients with neoplastic disease.

Topics covered may be either very broad or quite focused and, in general, are authored by a renowned expert in the particular area.

Its exceptionally wide circulation within the clinical cancer community insures broad exposure of its editorial material.

In addition, ONCOLOGY is included in Medline, Excerpta Medica, EMBASE, and the Cancer Line and CancerLit databases at the National Cancer Institute.

Each article that appears in the journal is referred to one, two, or three reviewers, who are asked to write a short commentary to be published alongside the article.

These commentaries broaden the reader’s perspective on the topic being discussed as they serve to highlight areas of consensus or disagreement among professionals most familiar with the topic in question.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.8

SJR (SCImago Journal Rank)

Year	Value
2024	0.489

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	85

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Delay in Cancer Screening and Diagnosis During the COVID-19 Pandemic: What Is the Cost?

  Citation: 46

  Authors: Julie

• Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates

  Citation: 21

  Authors: Aiko, Neelima, Aditya

• Patient-Reported Outcomes of Pain and Related Symptoms in Integrative Oncology Practice and Clinical Research: Evidence and Recommendations

  Citation: 17

  Authors: W. Iris, Danielle, Maggie, Anita, Ting, Viraj, Xin Shelley

• Profilin 1 Protein and Its Implications for Cancers

  Citation: 14

  Authors: Ya, Yang, Rongjun, Chengping, Yichen

• Minority Enrollment to Clinical Trials: Road to Increased Access

  Citation: 14

  Authors: Julie M.

• Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US

  Citation: 9

  Authors:

• Cancer Pain and Opioid Use Disorder

  Citation: 9

  Authors:

• Current Frontline Treatment of Diffuse Large B-Cell Lymphoma

  Citation: 9

  Authors:

• Sjögren Syndrome Induced by Immune Checkpoint Inhibitors in a Patient with Advanced Renal Cell Carcinoma

  Citation: 8

  Authors: Emilio, Yuly, Francisco, Nayeli, Gabriela, Monica, Armando, María

• Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer

  Citation: 7

  Authors: Alison, Ana, Philip, Eric, Elizabeth, Tari

---